FTISADTSK acetate

SKU: orb1692377

Description

FTISADTSK acetate is a stable signature peptide derived from Trastuzumab, suitable for quantification via selected reaction monitoring (SRM). It serves as a critical analytical standard in pharmacokinetic and bioanalytical studies, supporting both in vitro and in vivo research on therapeutic antibody monitoring.

Research Area

Metabolism Research

Images & Validation

−

Key Properties

−

Target	Drug Metabolite

Storage & Handling

−

Storage	-20°C
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Drug Metabolite

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols